The Lagos State government recently approved some private health facilities to administer COVID-19 vaccines in the state.
Olukayode Jaiyeola/NurPhoto via Getty Images
Paxlovid is one potential COVID drug for use at home. The idea is these can potentially be prescribed at the first sign of infection to prevent serious illness and death.
People queuing to get vaccinated. Instead of vaccinating 12-17 year olds, government should focus on giving boosters to people who need it.
Shutterstock
The focus of the government seems to be about how many people can get vaccinated rather than ensuring the greatest protection against severe disease and deaths.
Jennifer Juno, The Peter Doherty Institute for Infection and Immunity and Stephen Kent, The University of Melbourne
Protection from infection wanes over time. So boosters will offer extra protection and hopefully reduce the spread of the virus even further.
Discuss with your doctor whether or not you need a booster – and if so, which vaccine will work best for you.
Justin Sullivan/Getty Images News via Getty Images
As boosters are authorized for all three COVID-19 shots available in the US, the ability to swap out vaccine types looks to be a boon to the immune system.
In light of mounting research showing the serious risks of contracting COVID-19 during pregnancy, the CDC is re-upping its urgency that pregnant women get their shots.
There are very few situations where someone can’t have a COVID vaccine for medical reasons.
Public health officials have been waiting for good data before making any decisions about booster shots for people who received Johnson & Johnson’s Janssen COVID-19 vaccine.
AP Photo/Mary Altaffer
Your body produces antibodies after an infection or vaccine, but these slowly decline over time. New Johnson & Johnson data sheds light on the duration of protection and the need for booster shots.
The FDA and CDC are recommending use of a third shot, or “booster dose” for certain groups of people in the U.S.
Patrick T. Fallon/AFP via Getty Images
Fault lines between the FDA and CDC regulatory processes have been on full display in the decisions over which groups of Americans should receive the Pfizer booster shot.
Documents show Pfizer reached out in June 2020 for a personal meeting with federal Health Minister Greg Hunt, but instead the contact was left to a senior health department official.
You’ll read lots of different figures on this — six months, eight months, more — and that’s because the research is ongoing. We don’t yet have a concrete answer.
Most kids will be unvaccinated if schools in the two largest states re-open in term 4. There may still be community transmission, but there are measures we can take to shield kids from the virus.
People getting vaccinated may still have questions about COVID-19 vaccines, like why it takes two doses — and then two weeks — to take full effect.
THE CANADIAN PRESS/Ryan Remiorz
A medical student answers questions he gets asked at a COVID-19 vaccine clinic: Efficacy versus real-world effectiveness, immune response and how the mRNA vaccines compare to vaccines already in wide use.
FDA approval of Pfizer’s COVID-19 vaccine may boost vaccination rates among those who have been hesitant to get the shot.
(AP Photo/Jessica Hill)
The U.S. FDA has approved the first COVID-19 vaccine. How is approval different from emergency use authorization, and what difference will it make to a vaccine that’s already in global use?
Not vaccinating children means living with the knowledge we haven’t done everything possible to ensure they don’t transmit COVID to more vulnerable people.
Archa Fox, The University of Western Australia and Thomas Preiss, Australian National University
Doses of the Moderna vaccine will be available in Australia from mid-September. So if you’re in an eligible group you could be offered either Pfizer or Moderna. Here’s how they compare.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute